National Health Investors, Inc.
NHI · NYSE
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Valuation | ||||
| PEG Ratio | 68.92 | 0.04 | -1.64 | -0.77 |
| FCF Yield | 6.70% | 7.46% | 7.73% | 8.02% |
| EV / EBITDA | 15.75 | 13.60 | 22.81 | 18.04 |
| Quality | ||||
| ROIC | 7.27% | 7.47% | 1.00% | 2.65% |
| Gross Margin | 96.67% | 96.40% | 96.48% | 96.10% |
| Cash Conversion Ratio | 1.52 | 1.37 | 2.83 | 1.88 |
| Growth | ||||
| Revenue 3-Year CAGR | 6.41% | 2.30% | -5.80% | -2.07% |
| Free Cash Flow Growth | 12.72% | -0.00% | -14.27% | -3.44% |
| Safety | ||||
| Net Debt / EBITDA | 4.25 | 4.28 | 7.42 | 5.70 |
| Interest Coverage | 3.28 | 3.22 | 1.81 | 2.60 |
| Efficiency | ||||
| Inventory Turnover | 0.00 | 0.00 | 0.00 | 0.00 |
| Cash Conversion Cycle | -830.97 | -693.18 | -523.07 | -70.57 |